东京热福利视频导航|日韩无码不卡一区|成人高清手机在线|在厨房乱子伦对白一区二区|中文字幕网址导航|国产原创在线亚洲黄色大片高清无码|深爱激情五月丁香亚洲综合社区|成人在线手机视频|浮力影院成人A片|日韩限制电影在线观看

Psychopharmacology
  • 數(shù)據(jù)庫(kù)收錄SCIE
  • 創(chuàng)刊年份1959年
  • 年發(fā)文量201
  • H-index181

Psychopharmacology

期刊中文名:精神藥理學(xué)ISSN:0033-3158E-ISSN:1432-2072

該雜志國(guó)際簡(jiǎn)稱:PSYCHOPHARMACOLOGY,是由出版商Springer Berlin Heidelberg出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以NEUROSCIENCES研究為重點(diǎn),主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有很高的學(xué)術(shù)影響力。

基本信息:
期刊簡(jiǎn)稱:PSYCHOPHARMACOLOGY
是否OA:未開放
是否預(yù)警:
Gold OA文章占比:29.69%
出版信息:
出版地區(qū):GERMANY
出版周期:Semimonthly
出版語(yǔ)言:English
出版商:Springer Berlin Heidelberg
評(píng)價(jià)信息:
中科院分區(qū):3區(qū)
JCR分區(qū):Q2
影響因子:3.5
CiteScore:7.1
雜志介紹 中科院JCR分區(qū) JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

雜志介紹

Psychopharmacology雜志介紹

《Psychopharmacology》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊,中文名稱精神藥理學(xué),本刊主要出版、報(bào)道醫(yī)學(xué)-NEUROSCIENCES領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.5,最新CiteScore 指數(shù)為7.1。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有:

  • Desulfovibrio confers resilience to the comorbidity of pain and anxiety in a mouse model of chronic inflammatory pain

    Author: Wu, Zifeng; Liu, Hanyu; Yan, Enshi; Zhang, Xinying; Wang, Yuanyuan; Huang, Chaoli; He, Teng; Miao, Liying; Yang, Ling; Jiang, Riyue; Qi, Changyong; Liu, Cunming; Wang, Di; Yang, Chun

  • The effects of serotonergic psychedelics in synaptic and intrinsic properties of neurons in layer II/III of the orbitofrontal cortex

    Author: Tang, Zi-Hang; Yu, Zhi-Peng; Li, Qiong; Zhang, Xiao-Qin; Muhetaer, Kadeliya; Wang, Zheng-Chun; Xu, Peng; Shen, Hao-Wei

  • The M1 muscarinic acetylcholine receptor regulates the surface expression of the AMPA receptor subunit GluA2 via PICK1

    Author: Zhu, Zengyan; Wang, Wenjuan; Gu, Chao; Wang, Mei; Yan, Yinghui

  • Chronic restraint stress-induced depression-like behavior is mediated by upregulation of melanopsin expression in C57BL/6 mice retina

    Author: Fu, Yingmei; Liu, Shanshan; Dong, Yigang; Gan, Yixia; Guo, Xiaoyun; Liu, Hongmei; Xu, Qingqing; Yuan, Ruixue; Ning, Ailing; Hong, Wu; Peng, Yanmin; Yu, Shunying

英文介紹

Psychopharmacology雜志英文介紹

Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

中科院SCI分區(qū)

Psychopharmacology雜志中科院分區(qū)信息

2023年12月升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

NEUROSCIENCES
神經(jīng)科學(xué) 3區(qū)

PHARMACOLOGY & PHARMACY
藥學(xué) 3區(qū)

PSYCHIATRY
精神病學(xué) 3區(qū)

2022年12月升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

NEUROSCIENCES
神經(jīng)科學(xué) 3區(qū)

PHARMACOLOGY & PHARMACY
藥學(xué) 3區(qū)

PSYCHIATRY
精神病學(xué) 3區(qū)

2021年12月舊的升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

PHARMACOLOGY & PHARMACY
藥學(xué) 2區(qū)

NEUROSCIENCES
神經(jīng)科學(xué) 3區(qū)

PSYCHIATRY
精神病學(xué) 3區(qū)

2021年12月基礎(chǔ)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

NEUROSCIENCES
神經(jīng)科學(xué) 3區(qū)

PHARMACOLOGY & PHARMACY
藥學(xué) 3區(qū)

PSYCHIATRY
精神病學(xué) 3區(qū)

2021年12月升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

PHARMACOLOGY & PHARMACY
藥學(xué) 2區(qū)

NEUROSCIENCES
神經(jīng)科學(xué) 3區(qū)

PSYCHIATRY
精神病學(xué) 3區(qū)

2020年12月舊的升級(jí)版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

NEUROSCIENCES
神經(jīng)科學(xué) 3區(qū)

PHARMACOLOGY & PHARMACY
藥學(xué) 3區(qū)

PSYCHIATRY
精神病學(xué) 3區(qū)

中科院SCI分區(qū):是中國(guó)科學(xué)院文獻(xiàn)情報(bào)中心科學(xué)計(jì)量中心的科學(xué)研究成果。期刊分區(qū)表自2004年開始發(fā)布,延續(xù)至今;2019年推出升級(jí)版,實(shí)現(xiàn)基礎(chǔ)版、升級(jí)版并存過(guò)渡,2022年只發(fā)布升級(jí)版,期刊分區(qū)表數(shù)據(jù)每年底發(fā)布。 中科院分區(qū)為4個(gè)區(qū)。中科院分區(qū)采用刊物前3年影響因子平均值進(jìn)行分區(qū),即前5%為該類1區(qū),6%~20%為2區(qū)、21%~50%為3區(qū),其余的為4區(qū)。1區(qū)和2區(qū)雜志很少,雜志質(zhì)量相對(duì)也高,基本都是本領(lǐng)域的頂級(jí)期刊。

JCR分區(qū)(2023-2024年最新版)

Psychopharmacology雜志 JCR分區(qū)信息

按JIF指標(biāo)學(xué)科分區(qū)
學(xué)科:NEUROSCIENCES
收錄子集:SCIE
分區(qū):Q2
排名:109 / 310
百分位:

65%

學(xué)科:PHARMACOLOGY & PHARMACY
收錄子集:SCIE
分區(qū):Q2
排名:100 / 354
百分位:

71.9%

學(xué)科:PSYCHIATRY
收錄子集:SCIE
分區(qū):Q2
排名:75 / 276
百分位:

73%

按JCI指標(biāo)學(xué)科分區(qū)
學(xué)科:NEUROSCIENCES
收錄子集:SCIE
分區(qū):Q2
排名:109 / 310
百分位:

65%

學(xué)科:PHARMACOLOGY & PHARMACY
收錄子集:SCIE
分區(qū):Q2
排名:97 / 354
百分位:

72.74%

學(xué)科:PSYCHIATRY
收錄子集:SCIE
分區(qū):Q2
排名:85 / 276
百分位:

69.38%

JCR分區(qū):JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。

CiteScore 評(píng)價(jià)數(shù)據(jù)(2024年最新版)

Psychopharmacology雜志CiteScore 評(píng)價(jià)數(shù)據(jù)

  • CiteScore 值:7.1
  • SJR:1.053
  • SNIP:0.861
學(xué)科類別 分區(qū) 排名 百分位
大類:Pharmacology, Toxicology and Pharmaceutics 小類:Pharmacology Q2 88 / 313

72%

歷年影響因子和期刊自引率

投稿經(jīng)驗(yàn)

Psychopharmacology雜志投稿經(jīng)驗(yàn)

該雜志是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,該雜志在NEUROSCIENCES綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國(guó)際優(yōu)秀雜志,一般投稿過(guò)審時(shí)間都較長(zhǎng),投稿過(guò)審時(shí)間平均 較快,2-4周 ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢客服。

免責(zé)聲明

若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。